Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

The price of Gilead Sciences, Inc (NASDAQ: GILD) closed at $108.28 in the last session, up 0.06% from day before closing price of $108.22. In other words, the price has increased by $0.06 from its previous closing price. On the day, 3.57 million shares were traded. GILD stock price reached its highest trading level at $109.38 during the session, while it also had its lowest trading level at $107.75.

Ratios:

We take a closer look at GILD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.68. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.37. In the meantime, Its Debt-to-Equity ratio is 1.30 whereas as Long-Term Debt/Eq ratio is at 1.16.

On March 04, 2025, Oppenheimer reiterated its Outperform rating and also lowered its target price recommendation from $115 to $132.

Deutsche Bank Upgraded its Hold to Buy on February 18, 2025, while the target price for the stock was maintained at $120.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 15 ’25 when Mercier Johanna sold 3,000 shares for $111.03 per share. The transaction valued at 333,090 led to the insider holds 117,168 shares of the business.

Dickinson Andrew D sold 2,500 shares of GILD for $277,575 on Jul 15 ’25. The Chief Financial Officer now owns 162,610 shares after completing the transaction at $111.03 per share. On Jul 15 ’25, another insider, JOHANNA MERCIER, who serves as the Officer of the company, bought 3,000 shares for $111.03 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GILD now has a Market Capitalization of 134692741120 and an Enterprise Value of 154071416832. As of this moment, Gilead’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.77, and their Forward P/E ratio for the next fiscal year is 12.65. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.70 while its Price-to-Book (P/B) ratio in mrq is 7.04. Its current Enterprise Value per Revenue stands at 5.362 whereas that against EBITDA is 11.226.

Stock Price History:

The Beta on a monthly basis for GILD is 0.35, which has changed by 0.49454498 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, GILD has reached a high of $119.96, while it has fallen to a 52-week low of $70.78. The 50-Day Moving Average of the stock is -0.06%, while the 200-Day Moving Average is calculated to be 7.72%.

Shares Statistics:

According to the various share statistics, GILD traded on average about 8.28M shares per day over the past 3-months and 5526830 shares per day over the past 10 days. A total of 1.25B shares are outstanding, with a floating share count of 1.24B. Insiders hold about 0.16% of the company’s shares, while institutions hold 87.00% stake in the company. Shares short for GILD as of 1749772800 were 22993007 with a Short Ratio of 2.54, compared to 1747267200 on 24676861. Therefore, it implies a Short% of Shares Outstanding of 22993007 and a Short% of Float of 1.8499999999999999.

Dividends & Splits

The forward annual dividend rate for GILD is 3.12, which was 3.1 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.028645352The stock’s 5-year Average Dividend Yield is 3.95. The current Payout Ratio is 805.23% for GILD, which recently paid a dividend on 2025-06-13 with an ex-dividend date of 2025-06-13. Stock splits for the company last occurred on 2013-01-28 when the company split stock in a 2:1 ratio.

Earnings Estimates

The market rating for Gilead Sciences, Inc (GILD) is a result of the insights provided by 20.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $2.17, with high estimates of $2.4 and low estimates of $1.99.

Analysts are recommending an EPS of between $8.6 and $7.71 for the fiscal current year, implying an average EPS of $7.98. EPS for the following year is $8.51, with 27.0 analysts recommending between $10.05 and $6.45.

Revenue Estimates

According to 19 analysts, the current quarter’s revenue is expected to be $6.95B. It ranges from a high estimate of $7.27B to a low estimate of $6.74B. As of the current estimate, Gilead Sciences, Inc’s year-ago sales were $6.95BFor the next quarter, 19 analysts are estimating revenue of $7.39B. There is a high estimate of $7.58B for the next quarter, whereas the lowest estimate is $7.2B.

A total of 27 analysts have provided revenue estimates for GILD’s current fiscal year. The highest revenue estimate was $29.45B, while the lowest revenue estimate was $28.28B, resulting in an average revenue estimate of $28.67B. In the same quarter a year ago, actual revenue was $28.75BBased on 27 analysts’ estimates, the company’s revenue will be $29.75B in the next fiscal year. The high estimate is $31.88B and the low estimate is $28.7B.